West Nile Virus–Associated Hospitalizations, California, 2004–2017
Authors:
- 11 June 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 73 (3) , 441-447
Abstract
Background: West Nile virus (WNV) is the most commonly reported mosquito-borne disease in the USA. California reports more WNV disease than any other state. Methods: We identified WNV-associated hospitalizations from 2004 through 2017 in California and estimated hospitalization incidence using Patient Discharge Data. We described demographic, geographic, and clinical characteristics of WNV hospitalizations; identified risk factors for in-hospital death; and tabulated hospitalization charges. Results: From 2004 through 2017, 3109 Californians were hospitalized with WNV (median, 214 patients/year; range, 72–449). The majority were male (1983; 63.8%) and aged ≥60 years (1766; 56.8%). The highest median annual hospitalization rate (0.88 hospitalizations/100 000 persons) was in the Central Valley, followed by southern California (0.59 hospitalizations/100 000 persons). Most patients (2469; 79.4%) had ≥1 underlying condition, including hypertension, cardiovascular disease, diabetes, chronic kidney disease, or immunosuppression due to medications or disease. Median hospitalization length of stay was 12 days (interquartile range, 6–23 days). During hospitalization, 1317 (42%) patients had acute respiratory failure and/or sepsis/septic shock, 772 (24.8%) experienced acute kidney failure, and 470 (15.1%) had paralysis; 272 (8.8%) patients died. Nearly 47% (1444) of patients were discharged for additional care. During these 14 years, $838 680 664 (mean $59.9 million/year) was charged for WNV hospitalizations, 73.9% through government payers at a median charge of $142 321/patient. Conclusions: WNV-associated hospitalizations were substantial and costly in California. Hospitalization incidence was higher in males, elderly persons, and patients with underlying conditions. WNV persists as a costly and severe public health threat in California.Keywords
Funding Information
- Centers for Disease Control and Prevention
- Epidemiology and Laboratory Capacity (G NU50CK000410-04-01)
This publication has 28 references indexed in Scilit:
- Medical Risk Factors for Severe West Nile Virus Disease, United States, 2008–2010The American Journal of Tropical Medicine and Hygiene, 2012
- Economic Cost Analysis of West Nile Virus Outbreak, Sacramento County, California, USA, 2005Emerging Infectious Diseases, 2010
- Efficacy of Aerial Spraying of Mosquito Adulticide in Reducing Incidence of West Nile Virus, California, 2005Emerging Infectious Diseases, 2008
- The Long-Term Outcomes of Human West Nile Virus InfectionClinical Infectious Diseases, 2007
- Manifestations of West Nile neuroinvasive diseaseReviews in Medical Virology, 2006
- Risk factors for encephalitis and death from West Nile virus infectionEpidemiology and Infection, 2006
- West Nile Virus–associated Flaccid ParalysisEmerging Infectious Diseases, 2005
- The Epidemic of West Nile Virus in the United States, 2002Vector-Borne and Zoonotic Diseases, 2004
- West Nile encephalitisBMJ, 2003
- Human Equine Encephalomyelitis and St. Louis Encephalitis in California, 1939-1941American Journal of Public Health and the Nations Health, 1942